Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Rivas

Showing results (241-250 of 307) with videos related to

Pageof 31
Sort By:
Journal of Food Protection|April 10, 2010
Prevalence, characterization, and genotypic analysis of Escherichia coli O157:H7/NM from selected beef exporting abattoirs of ArgentinaM O Masana, G A Leotta, L L Del Castillo, et al.
Folia Microbiologica|November 11, 2022
Microalgae, a current option for the bioremediation of pharmaceuticals: a reviewManuel Aaaron Gayosso-Morales, Andrea M Rivas-Castillo, Isaac Lucas-Gómez, et al.
Viruses|May 12, 2018
Molecular and Clinical Characterization of Chikungunya Virus Infections in Southeast MexicoKame A Galán-Huerta, Erik Martínez-Landeros, Juan L Delgado-Gallegos, et al.
The Journal of Clinical Endocrinology and Metabolism|May 1, 1997
Bone loss and turnover after cardiac transplantationE Shane, M Rivas, D J McMahon, et al.
British Journal of Pharmacology|November 29, 2021
Proteinase-activated receptor-2 antagonist C391 inhibits Alternaria-induced airway epithelial signalling and asthma indicators in acute exposure mouse modelsCandy M Rivas, Michael C Yee, Kenneth J Addison, et al.
Archivos Espanoles De Urologia|November 6, 2001
[Our experience with adrenalectomy (1994-2000). Overall review]M E Gómez Díaz, M E García-Sastre García, M Rivas del Fresno, et al.
Journal of Viral Hepatitis|August 19, 2007
Additive effect of ethanol and HCV subgenomic replicon expression on COX-2 protein levels and activityK Trujillo-Murillo, O Alvarez-Martínez, L Garza-Rodríguez, et al.
British Journal of Pharmacology|July 4, 2015
The novel PAR2 ligand C391 blocks multiple PAR2 signalling pathways in vitro and in vivoScott Boitano, Justin Hoffman, Andrea N Flynn, et al.
Viruses|January 22, 2022
Prevalence of SARS-CoV-2 Variants of Concern and Variants of Interest in COVID-19 Breakthrough Infections in a Hospital in Monterrey, MexicoKame A Galán-Huerta, Samantha Flores-Treviño, Daniel Salas-Treviño, et al.
Acta Pharmaceutica (Zagreb, Croatia)|September 14, 2023
Formulation and optimization of polymeric nanoparticles loaded with riolozatrione: a promising nanoformulation with potential antiherpetic activityGuadalupe Y Solís-Cruz, Rocío Alvarez-Roman, Verónica M Rivas-Galindo, et al.
Pageof 31

Showing results (241-250 of 307) with videos related to

Sort By:
Pageof 31
Journal of Food Protection|April 10, 2010
Prevalence, characterization, and genotypic analysis of Escherichia coli O157:H7/NM from selected beef exporting abattoirs of ArgentinaM O Masana, G A Leotta, L L Del Castillo, et al.
Folia Microbiologica|November 11, 2022
Microalgae, a current option for the bioremediation of pharmaceuticals: a reviewManuel Aaaron Gayosso-Morales, Andrea M Rivas-Castillo, Isaac Lucas-Gómez, et al.
Viruses|May 12, 2018
Molecular and Clinical Characterization of Chikungunya Virus Infections in Southeast MexicoKame A Galán-Huerta, Erik Martínez-Landeros, Juan L Delgado-Gallegos, et al.
The Journal of Clinical Endocrinology and Metabolism|May 1, 1997
Bone loss and turnover after cardiac transplantationE Shane, M Rivas, D J McMahon, et al.
British Journal of Pharmacology|November 29, 2021
Proteinase-activated receptor-2 antagonist C391 inhibits Alternaria-induced airway epithelial signalling and asthma indicators in acute exposure mouse modelsCandy M Rivas, Michael C Yee, Kenneth J Addison, et al.
Archivos Espanoles De Urologia|November 6, 2001
[Our experience with adrenalectomy (1994-2000). Overall review]M E Gómez Díaz, M E García-Sastre García, M Rivas del Fresno, et al.
Journal of Viral Hepatitis|August 19, 2007
Additive effect of ethanol and HCV subgenomic replicon expression on COX-2 protein levels and activityK Trujillo-Murillo, O Alvarez-Martínez, L Garza-Rodríguez, et al.
British Journal of Pharmacology|July 4, 2015
The novel PAR2 ligand C391 blocks multiple PAR2 signalling pathways in vitro and in vivoScott Boitano, Justin Hoffman, Andrea N Flynn, et al.
Viruses|January 22, 2022
Prevalence of SARS-CoV-2 Variants of Concern and Variants of Interest in COVID-19 Breakthrough Infections in a Hospital in Monterrey, MexicoKame A Galán-Huerta, Samantha Flores-Treviño, Daniel Salas-Treviño, et al.
Acta Pharmaceutica (Zagreb, Croatia)|September 14, 2023
Formulation and optimization of polymeric nanoparticles loaded with riolozatrione: a promising nanoformulation with potential antiherpetic activityGuadalupe Y Solís-Cruz, Rocío Alvarez-Roman, Verónica M Rivas-Galindo, et al.
Pageof 31